Viral Vector and Plasmid DNA Manufacturing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Viral Vector and Plasmid DNA Manufacturing Market was estimated at US$ 911.28 million in 2020 and expected to reach US$ 3701.47 million by 2028, expanding growth at a noteworthy CAGR of 14% during the forecast period 2022 to 2028.

Viral vectors are used as carriers for transferring genetic material from one organism to another. Viral vector production can be performed in two types of culture systems: suspension cell cultures and adherent cell systems. Existing laboratory processes of adherent cell systems such as multilayer flasks, hollow fiber technology, T-flasks and roller bottles for large-scale fabrication of viral vectors suffer from scalability such as larger space requirements and increased manual workload. Plasmid DNA is extrachromosomal DNA found in bacteria that are usually circular in shape. Genetic engineers use plasmid DNA to create recombinant DNA to pass genetic material to another organism. Plasmid DNA is limited by some biological barriers, such as endosomal attack, renal clearance, and degradation by serum endonucleases. In addition, GMP (Good Manufacturing Practice) grade plasmid DNA is essential for direct gene transfer to humans. Thus, to date, approximately 70% of gene therapy clinical trials involve viral vector systems.

Market Segments

By Vector Type

• Adenovirus
• Plasmid DNA
• Lentivirus
• Retrovirus
• AAV
• Others

By Application

• Gene Therapy
• Antisense &RNAi
• Cell Therapy
• Vaccinology

By Workflow

• Upstream Processing
• Downstream Processing

By Disease

• Genetic Disorders
• Cancer
• Infectious Diseases
• Others

Key Players

• Novasep
• Aldevron
• MerckWaismanBiomanufacturing
• Creative Biogene
• The Cell and Gene Therapy Catapult
• Cobra Biologics
• uniQure N.V.
• Addgene
• FUJIFILM Holdings Corporation
• Oxford Biomedicaplc
• Takara Bio Inc.

Scope of the Report

The research study analyzes the global Viral Vector and Plasmid DNA Manufacturing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Viral Vector and Plasmid DNA Manufacturing Market Report

1. What was the Viral Vector and Plasmid DNA Manufacturing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Viral Vector and Plasmid DNA Manufacturing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Viral Vector and Plasmid DNA Manufacturing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.